Abstract
Interleukin-10 (IL-10) is a pleiotropic immunosuppressive and immunostimulatory cytokine. In autoimmune diabetes of the nonobese diabetic (NOD) mouse, IL-10 has exhibited paradoxical effects. Systemic IL-10 expression prevented or delayed diabetes onset in NOD mice while local expression of IL-10 did not. As antigen-presenting cells (APCs) play a central role in the generation of primary T cell responses, the direct role of this gene in pancreatic beta (β) cell is not clear. The effects of IL-10 on the protection of β cells in vitro were examined. In the present study, we examined the effects of adenovirus vector-mediated murine IL-10 (mIL-10) gene transfer to islet cell line RINm5F cells in vitro and to explore if IL-10 overexpression may prevent cytokine-mediated cytotoxicity. We had established the recombinant adenovirus vector containing mIL-10 genes (Ad-mIL-10) successfully. After infection of Ad-mIL-10, both mRNA and protein were expressed in RINm5F cells. Moreover, RINm5F cells secreted IL-10 protein into culture medium. Ad-mIL-10 prevented IL-1β-mediated nitric oxide production from β cells in vitro as well as the suppression of β cells function as determined by glucose-stimulated insulin production. Furthermore, Ad-mIL-10 gene transfer led to a profound reduction of Fas-expressing β cells and caspase-3 activity which were induced by IL-1β and the apoptotic rates of Ad-mIL-10 group were decreased. These findings show that IL-10 gene transfer to β cells may be beneficial in maintaining cells function, protecting islet cells from apoptosis—mediated by factors, which showed the potential therapy for type 1 diabetes mellitus.
Similar content being viewed by others
References
Atkinson MA, Eisenbarth GS (2001) Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358(9277):221–229
Falcone M, Sarvetnick N (1999) The effect of local production of cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Clin Immunol 90(1):2–9
Rabinovitch A, Suarez-Pinzon WL (1998) Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 55(8):1139–1149
Zhang YC, Pileggi A, Agarwal A, Molano RD, Powers M, Brusko T et al (2003) Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice. Diabetes 52(3):708–716
Fiorentino DF, Bond MW, Mosmann TR (1989) Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170(6):2081–2095
Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683–765
Teros T, Hakala R, Ylinen L, Liukas A, Arvilommi P, Sainio-Pollanen S et al (2000) Cytokine balance and lipid antigen presentation in the NOD mouse pancreas during development of insulitis. Pancreas 20(2):191–196
Szelachowska M, Kretowski A, Kinalska I (1998) Decreased in vitro IL-4 [corrected] and IL-10 production by peripheral blood in first degree relatives at high risk of diabetes type-I. Horm Metab Res 30(8):526–530
Pennline KJ, Roque-Gaffney E, Monahan M (1994) Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol 71(2):169–175
Zheng XX, Steele AW, Hancock WW, Stevens AC, Nickerson PW, Roy-Chaudhury P et al (1997) A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. J Immunol 158(9):4507–4513
Goudy K, Song S, Wasserfall C, Zhang YC, Kapturczak M, Muir A et al (2001) Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice. Proc Natl Acad Sci USA 98(24):13913–13918
Leibowitz G, Beattie GM, Kafri T, Cirulli V, Lopez AD, Hayek A et al (1999) Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes 48(4):745–753
Csete ME, Benhamou PY, Drazan KE, Wu L, McIntee DF, Afra R et al (1995) Efficient gene transfer to pancreatic islets mediated by adenoviral vectors. Transplantation 59(2):263–268
Kuttler B, Wanka H, Kloting N, Gerstmayer B, Volk HD, Sawitzki B et al (2007) Ex vivo gene transfer of viral interleukin-10 to BB rat islets: no protection after transplantation to diabetic BB rats. J Cell Mol Med 11(4):868–880
Holohan C, Szegezdi E, Ritter T, O’Brien T, Samali A (2008) Cytokine-induced beta-cell apoptosis is NO-dependent, mitochondria-mediated and inhibited by BCL-XL. J Cell Mol Med 12(2):591–606
Cardozo AK, Kruhoffer M, Leeman R, Orntoft T, Eizirik DL (2001) Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays. Diabetes 50(5):909–920
Marselli L, Dotta F, Piro S, Santangelo C, Masini M, Lupi R et al (2001) Th2 cytokines have a partial, direct protective effect on the function and survival of isolated human islets exposed to combined proinflammatory and Th1 cytokines. J Clin Endocrinol Metab 86(10):4974–4978
Souza KL, Gurgul-Convey E, Elsner M, Lenzen S (2008) Interaction between pro-inflammatory and anti-inflammatory cytokines in insulin-producing cells. J Endocrinol 197(1):139–150
Storling J, Binzer J, Andersson AK, Zullig RA, Tonnesen M, Lehmann R et al (2005) Nitric oxide contributes to cytokine-induced apoptosis in pancreatic beta cells via potentiation of JNK activity and inhibition of Akt. Diabetologia 48(10):2039–2050
Veluthakal R, Amin R, Kowluru A (2004) Interleukin-1 beta induces posttranslational carboxymethylation and alterations in subnuclear distribution of lamin B in insulin-secreting RINm5F cells. Am J Physiol 287(4):C1152–C1162
Zumsteg U, Frigerio S, Hollander GA (2000) Nitric oxide production and Fas surface expression mediate two independent pathways of cytokine-induced murine beta-cell damage. Diabetes 49(1):39–47
Stassi G, Todaro M, Richiusa P, Giordano M, Mattina A, Sbriglia MS et al (1995) Expression of apoptosis-inducing CD95 (Fas/Apo-1) on human beta-cells sorted by flow-cytometry and cultured in vitro. Transplant Proc 27(6):3271–3275
Darwiche R, Chong MM, Santamaria P, Thomas HE, Kay TW (2003) Fas is detectable on beta cells in accelerated, but not spontaneous, diabetes in nonobese diabetic mice. J Immunol 170(12):6292–6297
Weber-Nordt RM, Henschler R, Schott E, Wehinger J, Behringer D, Mertelsmann R et al (1996) Interleukin-10 increases Bcl-2 expression and survival in primary human CD34+ hematopoietic progenitor cells. Blood 88(7):2549–2558
Zhou JH, Broussard SR, Strle K, Freund GG, Johnson RW, Dantzer R et al (2001) IL-10 inhibits apoptosis of promyeloid cells by activating insulin receptor substrate-2 and phosphatidylinositol 3′-kinase. J Immunol 167(8):4436–4442
Wang Y, Lou S (2001) Direct protective effect of interleukin-10 on articular chondrocytes in vitro. Chin Med J 114(7):723–725
Bharhani MS, Borojevic R, Basak S, Ho E, Zhou P, Croitoru K (2006) IL-10 protects mouse intestinal epithelial cells from Fas-induced apoptosis via modulating Fas expression and altering caspase-8 and FLIP expression. Am J Physiol Gastrointest Liver Physiol 291(5):G820–G829
Acknowledgments
This project was supported by a grant from the Natural Science Foundation of Shandong province (grant no: Y2008C50). We appreciated Prof. Bing Luo and Dr. Zhi-hong Chen for their excellent technique assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xu, AJ., Zhu, W., Tian, F. et al. Recombinant adenoviral expression of IL-10 protects beta cell from impairment induced by pro-inflammatory cytokine. Mol Cell Biochem 344, 163–171 (2010). https://doi.org/10.1007/s11010-010-0539-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-010-0539-x